Cornercap Investment Counsel Inc Omeros Corp Transaction History
Cornercap Investment Counsel Inc
- $329 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding OMER
# of Institutions
124Shares Held
25.2MCall Options Held
228KPut Options Held
630K-
Black Rock Inc. New York, NY4.1MShares$35.4 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY4.01MShares$34.5 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$28.1 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$16.4 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.61MShares$13.8 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $541M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...